FDA May Expedite Vaccine

FDA May Expedite Vaccine

(AmericanProsperity.com) – The pressure to develop a COVID-19 vaccine mounts as Americans hope their lives can return to normal in the coming months. While one is likely still months away from completion, a recent interview in the Financial Times with the head of the FDA shed some light on the timeline and process.

Dr. Stephen Hahn, the Commissioner of the Food and Drug Administration (FDA), said his agency would consider early approval of a coronavirus vaccine. This could mean an emergency use authorization of the treatment for use by certain groups before the third phase of clinical trials finishes.

This raised many eyebrows, but Hahn assured Americans of his commitment to data instead of politics in an interview on CBS:

Experts anticipate phase three trials wrapping up in October or November, with a vaccine not being widely available to the general public until 2021.

As the election looms on the horizon, Americans and politicians must keep the race for the White House separate from the search for a coronavirus vaccine. This will help ensure any potential vaccine is thoroughly tested before being offered to everyone in our nation.

~Here’s to Your Prosperity!

Copyright 2020, AmericanProsperity.com